US Patent Issued to Juno Therapeutics on May 13 for "Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy" (Washington Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,296,010, issued on May 13, was assigned to Juno Therapeutics Inc. (Seattle).

"Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy" was invented by Chris Ramsborg (Seattle), Mark L. Bonyhadi (Sammamish, Wash.), Calvin Chan (Seattle) and Pascal Beauchesne (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates in some aspects to methods, cells, and compositions for preparing cells and compositions for genetic engineering and cell therapy. Provided in some embodiments are streamlined cell preparation methods, e.g., for isolation, processing, incubation, and genetic engine...